Drug companion protocol
Liraglutide (Saxenda)
Also known as: Saxenda
A GLP-1 receptor agonist prescribed for chronic weight management in adults and adolescents.
Quickstart Highlights
- Drug class
- GLP-1 receptor agonist
- Route
- Subcutaneous injection
- Schedule
- Daily subcutaneous injection
- Evidence score
- 82
Quickstart highlights
- šSubcutaneous injection
- š¬GLP-1 receptor agonist
- šļøPre-filled autoinjector pen
- šPrescription required
How this works
Mechanism of action and pharmacokinetic profile from published data.
Liraglutide is a GLP-1 (glucagon-like peptide-1) receptor agonist ā a daily-injected analogue of the gut hormone GLP-1. It increases glucose-dependent insulin secretion, suppresses glucagon, slows gastric emptying, and acts on hypothalamic GLP-1 receptors to reduce appetite. In Saxenda, the dose is 3.0 mg once daily (higher than the 1.2ā1.8 mg daily doses used in Victoza for type 2 diabetes). Saxenda is one of the earliest approved GLP-1 agonists for weight management and has the most extensive real-world safety data of this medicine class.
- Time to peak (Tmax)
- 8ā12 hours after a subcutaneous injection.
- Clearance
- Degraded via proteolytic pathways; no renal or hepatic dose adjustment required for mild-to-moderate impairment, though limited data exist for severe impairment.
- Elimination half-life
- Approximately 13 hours ā this is why Saxenda is injected once daily, unlike the once-weekly GLP-1 agonists.
- Bioavailability
- ~55% bioavailability after subcutaneous injection; ~98% albumin-bound.
Injection guide
Supplies, step-by-step technique, safety notes, and AU sharps disposal.
Supplies needed
- ā¦Your Saxenda pen ā Each pen contains 18 mg/3 mL of liraglutide (6 mg/mL). One pen provides multiple daily injections ā it will last varying numbers of days depending on your current dose in the escalation schedule.
- ā¦A new pen needle (each day) ā NovoFine or equivalent, 4 mm Ć 32G recommended. A fresh needle is required for every daily injection.
- ā¦Alcohol swab
- ā¦Sharps disposal container
Step-by-step
- 1Wash your hands
- 2Check the pen
The liquid should be clear and colourless. Check the remaining doses counter to confirm there is enough for your dose today. Check the expiry date.
- 3Attach a new needle
Remove the outer cap paper tab, push and twist the needle onto the pen, remove the outer cap (save it), then pull off and discard the inner needle cap.
- 4Dial your current dose
Turn the dose selector to your current prescribed dose: 0.6, 1.2, 1.8, 2.4, or 3.0 mg. Your dose increases weekly during the escalation period ā confirm your current week's target with your prescriber.
- 5Prime if this is a new pen
If this is a new pen, dial 0.6 mg, point the pen upward, and press the button until a drop appears. Repeat until a drop is seen.
- 6Choose and clean your injection site
Abdomen (not within 5 cm of the navel), upper thigh, or upper arm. Rotate the site daily ā not the same spot twice in a row. Clean with an alcohol swab.
- 7Inject
Hold the pen at 90° to the skin, press firmly and press the injection button all the way. Count slowly to 6 ā hold until the dose counter reads 0.
- 8Remove needle and dispose
Recap with the saved outer cap (one-hand scoop), unscrew, and drop into your sharps container.
- 9Return pen to fridge
Store between 2ā8°C. After first use the pen can be kept at room temperature (below 30°C) for up to 30 days.
Important notes
- !Never inject into a vein or muscle
- !Never share your pen
- !Rotate injection sites daily
With daily injections, rotation is especially important ā using the same spot causes lipohypertrophy (hardened fatty lumps) that impairs absorption.
- !Do not inject into scar tissue, bruises, or broken skin
- !A 4% weight-loss check applies at 16 weeks on 3.0 mg
If less than 4% of body weight has been lost by week 16 at the full dose, your prescriber will review whether to continue.
- !Tell all healthcare providers you are using Saxenda
Sharps disposal
- ā¦Sharps container ā do not place loose needles in household bins
- ā¦NestSafe mail-back (Australia) ā free from participating pharmacies
- ā¦EnviroSafe mail-back (Australia)
- ā¦Community pharmacy drop-off ā ask your dispensing pharmacy
Clinical Benefits & Side Effects
Observed outcomes, adverse effects, and lifecycle considerations from published trial data.
Benefits
Starting at 0.6 mg daily
Saxenda is injected once daily, beginning at 0.6 mg for the first week. This is a tolerability dose ā weight loss begins at 1.2 mg and above. Daily injection is a habit that takes a few days to settle into.
First injection ā taking the first step
This week is all about getting comfortable with your daily injection routine. You may feel mild nausea, especially after meals ā this is very common and a sign the medication is working in your body. Don't expect visible weight changes yet; your body is simply adjusting to a new medication.
Building the habit, riding the waves
Nausea may still be present, particularly in the mornings or after eating too quickly or too much. Try eating smaller portions and slowing down at meals to ease discomfort. You're still on a low starting dose ā be patient with yourself and focus on consistency over results.
Side effects may ease ā routine takes shape
Many people find nausea begins to settle a little by week three as the body adapts. You might also notice some mild fatigue or occasional headaches ā staying well hydrated can help with both. Keep showing up for your daily injection, even when it feels like not much is happening yet.
End of starting dose ā almost at escalation
You've completed your first month ā that's worth acknowledging. Some people notice a subtle reduction in hunger or slightly smaller portions feeling satisfying, but many don't yet ā both are completely normal. Your prescriber will likely guide a dose increase soon; follow your prescriber's instructions for the escalation schedule.
Reaching 1.8 mg and assessing early tolerability
The dose steps up weekly (0.6 ā 1.2 ā 1.8 ā 2.4 ā 3.0 mg). By week 4 most people are on 1.8 mg. GI side effects ā if they occur ā typically appear in the first 4 weeks and ease with time.
Dose escalation begins ā appetite shifts ahead
Your dose is stepping up this week, which may bring a temporary return of nausea or a new wave of side effects as your body adjusts to the higher level. This is expected and usually settles within a few days ā stick with small, simple meals and keep up your fluids. Appetite suppression often becomes more noticeable as the dose increases.
Target dose of 3.0 mg
The target dose is 3.0 mg daily. Your prescriber may hold you at a lower dose if it is effective and well tolerated. Most of the SCALE trial weight-loss data was generated at 3.0 mg.
Side effects
~19%
~32%; most common during dose escalation
Reported
Common; often in early weeks
~16%
Mild; generally transient
Very common; generally an intended effect
~21%
Lifecycle factors
A 4% weight-loss check applies at 16 weeks
If less than 4% of body weight has been lost by week 16 at 3 mg, current clinical guidelines suggest reviewing whether Saxenda is working for you. This is not a failure ā it means your prescriber will reassess.
Tell all medical teams about the daily injection
Delayed gastric emptying matters for surgical procedures. Also worth noting for any prescriber considering new oral medicines.
Track your progress in a simple journal or app
Keeping a brief weekly log ā noting your weight, energy, how meals felt, any side effects, and one non-scale win ā creates a valuable picture of your journey over time. It's also very motivating to look back at week two when you're at week ten and see how far you've come. A simple notes app on your phone, a dedicated app like MyFitnessPal, or even a paper notebook all work equally well.
Be open with your prescriber about side effects
Nausea, constipation, reflux, and fatigue are all common experiences on liraglutide ā and your prescriber wants to know about them. If side effects are significantly affecting your quality of life or your ability to eat and drink adequately, don't wait until your next scheduled appointment to mention it. Your prescriber may have practical strategies to help, or may adjust the pace of your dose escalation ā always follow your prescriber's instructions rather than making changes on your own.
Dispose of used needles safely using a sharps container
Used pen needles must never be placed in regular household bins ā they should be collected in an approved sharps disposal container. In Australia, you can obtain a free sharps container through the Sharps Disposal Program available at many community pharmacies, councils, and healthcare centres. Once full, return the sealed container to a participating pharmacy or collection point for safe disposal.
Important note
This content is intended for therapeutic educational purposes only and does not constitute medical advice, diagnosis, or treatment. All information presented is based on published clinical trial data. Always follow your prescriber's instructions.
Nutrition & practical guidance
Food, hydration, and adherence tips compiled from trial data and clinical companion content.
Food and hydration
ā Prefer
ā ļø Limit
Adherence tips
Rotate your injection sites consistently
Liraglutide is injected subcutaneously (under the skin) into the abdomen, upper thigh, or upper arm ā rotating between these sites each day helps prevent skin irritation and lumps from building up. Keep a simple mental or written log of where you injected last. Always follow your prescriber's instructions on injection technique, and if you're unsure, ask your pharmacist for a demonstration.
Let the pen reach room temperature before injecting
Injecting liraglutide straight from the fridge can increase stinging and discomfort at the injection site. Take your pen out 10ā15 minutes before your scheduled injection time to let it reach room temperature. Store unused pens in the fridge (2ā8°C), and once opened, the current pen can be kept at room temperature (below 30°C) for up to 30 days.
Daily injections become routine quickly
Most people find the first week of daily injections the hardest psychologically. Using the same time each day (e.g. with breakfast, or before bed) anchors it to an existing habit. The pen is designed to be simple ā once the technique is set, the injection itself takes under a minute.
Inject at the same time every day
Liraglutide is a once-daily injection and works best when taken at a consistent time each day ā morning tends to suit most people as it becomes part of a morning routine. Linking your injection to an existing habit (like making your morning coffee or brushing your teeth) makes it much easier to remember. Always follow your prescriber's instructions if they've recommended a specific time for you.
Prioritise protein at every meal
When your appetite is suppressed, it's easy to under-eat ā and when you do eat less, protein is the most important nutrient to prioritise to protect your muscle mass. Aim for a palm-sized portion of protein (chicken, fish, eggs, legumes, Greek yoghurt) at breakfast, lunch, and dinner. Even on days when you're not very hungry, a small high-protein meal is far better than skipping entirely.
The real-world dose matters for weight loss
All significant SCALE trial weight-loss data is at 3.0 mg daily. If you are held at 1.8 mg or 2.4 mg due to tolerability, it is worth an honest conversation with your prescriber about expected outcomes versus a weekly agent.
Eat smaller meals more frequently
Large meals are one of the most common triggers for nausea on liraglutide ā your stomach empties more slowly on this medication, so overshooting your new fullness threshold can feel very uncomfortable. Try eating 4ā5 smaller meals or snacks spread throughout the day rather than three large ones. Stopping at the first sign of fullness, rather than finishing your plate, is a habit worth building early.
Saxenda is a foundation, not a ceiling
If you respond well to Saxenda but your prescriber later discusses switching to a weekly agent, this is a clinical upgrade, not a sign of failure. The GLP-1 medicine class has evolved significantly since liraglutide was first approved.
Sip water steadily ā don't gulp large amounts at once
Drinking large volumes of water quickly can worsen bloating and nausea, especially around meal times. Instead, keep a 600 mL or 1 litre water bottle with you and sip steadily throughout the day, aiming for at least 2 litres total. Try not to drink large amounts of fluid during meals, as this can increase feelings of fullness and discomfort.
Try ginger or peppermint tea for nausea
Ginger tea is one of the most well-supported natural remedies for nausea and is safe for most people to use alongside their medication. Keep herbal tea bags on hand ā especially in the first four to six weeks ā and sip on a warm cup when nausea strikes. Peppermint tea is another great option if ginger isn't to your taste.
Progress is not just the number on the scales
Weight loss with liraglutide is typically gradual and won't follow a perfectly straight line ā some weeks the scales won't move even when you're doing everything right. Make a habit of tracking non-scale victories: improved sleep, more energy, smaller portions feeling satisfying, or feeling more comfortable in movement. These changes are meaningful and reflect real progress, even when the scales disagree.
The early weeks are the hardest ā keep going
Weeks one through four can genuinely be tough ā nausea, fatigue, and no visible results yet can make it hard to stay motivated. It's completely normal to wonder whether it's worth it during this phase. Most people find that side effects ease significantly after the adjustment period, and the benefits of the medication become much more apparent from around week five onwards. You're building the foundation right now.
Start with gentle movement ā not an intense gym programme
In the early weeks when nausea and fatigue are common, gentle movement is far more sustainable than jumping straight into a demanding exercise routine. A 20ā30 minute walk each day is an excellent starting point and pairs well with the medication's effects. As you feel better and your energy improves ā typically from around week six ā you can gradually build in strength training, which is particularly valuable for preserving muscle during weight loss.
Time exercise around your best-feeling window
If nausea is worse in the mornings after your injection, scheduling your walk or workout for the afternoon or evening when you're feeling better makes exercise far more enjoyable and sustainable. Listen to your body ā there's no single "right" time to exercise, and consistency matters far more than timing. Aim for at least 150 minutes of moderate movement per week as a long-term goal, in line with Australian physical activity guidelines.
Protect your sleep ā it directly supports weight management
Poor sleep increases hunger hormones (particularly ghrelin) and can partially counteract the appetite-regulating benefits of liraglutide. Aim for 7ā9 hours of quality sleep per night by keeping a consistent bedtime, limiting screen use in the hour before bed, and keeping your bedroom cool and dark. If disrupted sleep is an ongoing issue, it's worth raising with your prescriber as part of your broader health picture.
Safety and interactions
Share this information with your prescriber for personalised care decisions.
Who should not take this
Saxenda is a prescription medicine. Do not use if you have: ⢠A personal or family history of medullary thyroid carcinoma (MTC) ⢠Multiple endocrine neoplasia syndrome type 2 (MEN2) ⢠A known allergy or hypersensitivity to liraglutide or any ingredient in the product Use with caution (discuss with your prescriber) if you have: ⢠A history of pancreatitis ⢠Severe kidney or liver disease ⢠A history of suicidal ideation ā rare reports have been observed across weight-loss medicines ⢠Active or recent eating disorder Not recommended during pregnancy or breastfeeding. Saxenda is approved in AU for adults (18+) and in some regions for adolescents 12ā17 years. Always discuss your full medical history with your prescriber.
Known interactions
- Insulin and insulin secretagogues (e.g. sulfonylureas)significant
Increased hypoglycaemia risk. Prescribers typically reduce doses of other glucose-lowering agents when starting Saxenda.
- Oral contraceptivesmoderate
Slowed gastric emptying may reduce oral contraceptive absorption, particularly during dose escalation. Consider additional non-hormonal contraception.
- Narrow therapeutic index medicines (warfarin, anti-epileptics)moderate
Altered absorption timing. Additional monitoring may be warranted.
- Alcoholmoderate
Worsens nausea and dehydration; increases hypoglycaemia risk with other diabetes medicines.
Storage and handling
Store the Saxenda pen in the refrigerator at 2ā8°C (36ā46°F) until first use. ⢠After first use: use within 30 days, keeping at or below 30°C and protected from light. ⢠Do not freeze the pen ā freezing destroys the medicine. ⢠Keep the cap on when not in use. ⢠The pen is for single patient use only ā do not share.
Research evidence
Published studies connected to this peptide with dosage and outcomes context.
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes (LEADER)
Human trial Ā· 2016 Ā· New England Journal of Medicine Ā· n=9340 Ā· Adults with type 2 diabetes and high cardiovascular risk
9,340 adults with type 2 diabetes and high cardiovascular risk were randomised to liraglutide 1.8 mg daily or placebo for a median of 3.8 years. MACE occurred in 13.0% of liraglutide versus 14.9% of placebo participants (HR 0.87, 95% CI 0.78ā0.97), demonstrating cardiovascular safety and superiority.
Reported outcomes
- cardiovascular: MACE occurred in 13.0% liraglutide versus 14.9% placebo over median 3.8 years (HR 0.87) ā demonstrating CV safety and superiority in type 2 diabetes. (Primary outcome)
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management (SCALE Obesity)
Human trial Ā· 2015 Ā· New England Journal of Medicine Ā· n=3731 Ā· Adults with obesity (BMI ā„30) or overweight (BMI ā„27) with dyslipidaemia or hypertension, without type 2 diabetes
3,731 adults were randomised to liraglutide 3.0 mg once daily or placebo for 56 weeks, alongside diet and exercise counselling. Mean body-weight change was ā8.4% with liraglutide versus ā2.8% with placebo; 63.2% of liraglutide participants achieved ā„5% weight loss. Nausea and vomiting were the most common adverse events.
Reported outcomes
- weight_loss: Mean body-weight reduction of 8.4% at 56 weeks on 3.0 mg daily, versus 2.8% with placebo. (Primary outcome)
- cardiometabolic: Improvements in blood pressure, HbA1c, and lipids; 80% risk reduction in progression to type 2 diabetes in a prediabetes subgroup. (Secondary)
- responder_rate: 63.2% of liraglutide participants achieved ā„5% weight loss; 33.1% achieved ā„10%. (Secondary)
Reported dosage
- 3 mg Ā· once daily subcutaneous Ā· 56 weeks ā Reached after weekly escalation: 0.6ā1.2ā1.8ā2.4ā3.0 mg. Primary endpoint dose.
Get the full companion experience in Viora
Week-by-week reminders, food and symptom tracking, and the complete companion guide in one place.
Available on iOS and Android.